@hanse_mina@mastodon.social
Moscow-based biotech firm R-Pharm International has sued #Raiffeisen's Russian unit for 337.5 million euros ($390 million), court filings show, in a case that a Russian newspaper says is linked to R-Pharm's failure to sell an asset in Germany.
https://www.reuters.com/business/finance/moscow-based-pharma-firm-sues-raiffeisenbank-3375-million-euros-2025-08-05/
#Ukraine #Russia #EU #Germany #Austria